The FDA approved Valtroza, an olanzapine subcutaneous injection once a month for adults with schizophrenia. In a trial involving 675 patients, improvement in symptoms and functioning was observed, alongside weight gain similar to oral olanzapine. According to Dr. Eric Yoz, chief medical officer of Teva, the drug "provides a solution to a major barrier in treatment." Teva's stock reacted sharply on Wall Street.
Automatic translation by Google
Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.
Simple, useful, and kind of fun. The post Doctor shares 60-second dementia test that can help adults spot early mental decline appeared first on Upworthy.
Many people dealing with excess weight know the feeling: every attempt ends up in the same place. Weight loss, weight gain, and the sense that eventually "maybe nothing will work for me." Professor Itamar Raz, an expert in obesity and diabetes, knows this feeling well from the clinic, and suggests changing the mindset.
What should you do when a doctor recommends a critical and expensive medication that is not included in the public health basket, but the insurance company rejects the request, claiming the insurance policy lacks coverage? Before you exhaust savings or break down over a denial letter from the insurer, it is important to understand the financing mechanisms operating behind the scenes. A guide to exercising patient rights in Israel.
